骨髓增生异常综合征进展为急性白血病行自体造血干细胞移植1例  

Discussion of decitabine combined with autologous stem cell transplantation for acute leukemia progressed from myelodysplastic syndrome-one case report

作　　者：宋慧慧[1] 陈宝安[1] 刘苒[1] 丁家华[1] 高冲[1] 孙耘玉[1] 王骏[1] 程坚[1] 赵刚[1] 余正平[1] 鲍文[1] 

机构地区：[1]东南大学附属中大医院血液科,江苏南京210009

出　　处：《东南大学学报（医学版）》2010年第6期608-610,共3页Journal of Southeast University(Medical Science Edition)

基　　金："十一五"国家科技支撑计划课题子课题(2008BAI61B02)

摘　　要：地西他滨对骨髓增生异常综合征有肯定疗效,目前已成为治疗该病的一线用药。但是,如果地西他滨治疗的效果不肯定,下一步治疗的选择至关重要。我院最近对1例地西他滨治疗后进展为急性白血病的患者进行了自体造血干细胞移植,取得良好效果。Decitabine is now as the first-line drug for the treatment of myelodysplastic syndrome because of its certain effect.However,if the effect is uncertain,the choice of next treatment is important.We recently transplanted autologous stem cell transplantation to a myelodysplastic syndrome patient progressing to acute leukemia,good results were achieved.

关 键 词：地西他滨 自体造血干细胞移植 骨髓增生异常综合征 急性白血病 

分 类 号：R551.3[医药卫生—血液循环系统疾病] R733.71[医药卫生—内科学]